Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion Capital Partners, a life sciences-focused venture capital firm headquartered in the Netherlands. The SPAC completed its initial public offering in 2021 and targets acquisition opportunities in the European life sciences and healthcare sector, reflecting Forbion's deep domain expertise in biotechnology and medtech investing. The company filed a 10-Q with the SEC on August 14, 2023, under accession number 0001193125-23-211112, indicating it remained in its search phase at that reporting period. Investors seeking the full filing history, timeline data, and deal metrics for FRBN can sign up for complete coverage at SpacDesk.